Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABHD6 | Q9BV23 | 1/20 | 0.43 |
| ▸ | NLRP3 | Q96P20 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.40 |
| ▸ | KCNQ3 | O43525 | 1/20 | 0.39 |
| ▸ | KCNQ2 | O43526 | 1/20 | 0.39 |
| ▸ | KCNQ4 | P56696 | 1/20 | 0.39 |
| ▸ | KCNMA1 | Q12791 | 1/20 | 0.39 |
| ▸ | KCNQ5 | Q9NR82 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | XBP1 | P17861 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.38 |
| ▸ | RAB9A | P51151 | 2/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7950929 | 0.92 | ABHD6 (0.43) | ABHD6NLRP3MAPTNOTUMKCNQ3 | |
| SCHEMBL7212915 | 0.90 | KMT2A (0.39) | ABHD6MAPTNOTUMKMT2A | |
| SCHEMBL7213528 | 0.89 | KMT2A (0.40) | ABHD6MAPTNOTUMNPSR1KDM4E | |
| SCHEMBL7214134 | 0.88 | KMT2A (0.38) | ABHD6MAPTNOTUMKMT2A | |
| SCHEMBL7952869 | 0.87 | ABHD6 (0.43) | ABHD6MAPTNOTUMKCNQ3KCNQ2 | |
| SCHEMBL8058096 | 0.87 | CETP (0.38) | ABHD6NOTUMKMT2A | |
| SCHEMBL7208554 | 0.87 | KMT2A (0.39) | ABHD6MAPTNOTUMKMT2A | |
| SCHEMBL5755870 | 0.87 | NR1H2 (0.41) | ABHD6NLRP3NOTUMKDM4E | |
| SCHEMBL7207878 | 0.86 | CETP (0.37) | ABHD6NOTUMKMT2A | |
| SCHEMBL7951068 | 0.86 | ABHD6 (0.42) | ABHD6MAPTNOTUMKCNQ3KCNQ2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1056754-B1 | PHOSPHATE DERIVATIVES OF DIARYL 1,3,4-OXADIAZOLONE | BRISTOL MYERS SQUIBB CO (US) | 2003-10-22 | — | — | EP | disclosed |
| EP-1056730-A4 | BENZOATE DERIVATIVES OF DIARYL 1,3,4-OXADIAZOLONE | BRISTOL MYERS SQUIBB CO (US) | 2003-01-02 | — | — | EP | disclosed |
| EP-1051173-A4 | DERIVATIVES OF 1,3,4-OXADIAZOLONE | BRISTOL MYERS SQUIBB CO (US) | 2002-07-31 | — | — | EP | disclosed |
| EP-1150978-A4 | CARBAMATE DERIVATIVES OF DIARYL 1,3,4-OXADIAZOLONE | BRISTOL MYERS SQUIBB CO (US) | 2002-06-12 | — | — | EP | disclosed |
| EP-1056754-A4 | PHOSPHATE DERIVATIVES OF DIARYL 1,3,4-OXADIAZOLONE | BRISTOL MYERS SQUIBB CO (US) | 2002-03-06 | — | — | EP | disclosed |
| EP-1150978-A1 | CARBAMATE DERIVATIVES OF DIARYL 1,3,4-OXADIAZOLONE | BRISTOL-MYERS SQUIBB COMPANY (US) | 2001-11-07 | — | — | EP | disclosed |
| US-6297241-B1 | TREATMENT OF DISORDERS WHICH ARE RESPONSIVE TO THE OPENING OF THE LARGE CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS. | BRISTOL-MYERS SQUIBB COMPANY | 2001-10-02 | — | — | US | disclosed |
| US-6271249-B1 | Diphenyl imidazoles as potassium channel modulators | BRISTOL-MYERS SQUIBB COMPANY | 2001-08-07 | — | — | US | disclosed |
| US-6162817-A | Carbamate derivatives of diaryl 1,3,4-oxadiazolone | BRISTOL-MYERS SQUIBB COMPANY (US) | 2000-12-19 | — | — | US | disclosed |
| EP-1056754-A1 | PHOSPHATE DERIVATIVES OF DIARYL 1,3,4-OXADIAZOLONE | Bristol-Myers Squibb Company (US) | 2000-12-06 | — | — | EP | disclosed |
| WO-2000044745-A1 | CARBAMATE DERIVATIVES OF DIARYL 1,3,4-OXADIAZOLONE | BRISTOL-MYERS SQUIBB COMPANY (US) | 2000-08-03 | — | — | WO | disclosed |
| US-6077861-A | MODULATORS OF THE LARGE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM (BK) CHANNELS, THEREFORE, USEFUL IN THE TREATMENT OF ISCHEMIC STROKE | BRISTOL-MYERS SQUIBB COMPANY (US) | 2000-06-20 | — | — | US | disclosed |
| US-6034113-A | ANTIISCHEMIC AGENTS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2000-03-07 | — | — | US | disclosed |
| US-5977150-A | Amino acid derivatives of diaryl 1,3,4-oxadiazolone | BRISTOL-MYERS SQUIBB COMPANY (US) | 1999-11-02 | — | — | US | disclosed |
| US-5948802-A | Benzoate derivatives of diaryl 1,3,4-oxadiazolone | BRISTOL-MYERS SQUIBB COMPANY (US) | 1999-09-07 | — | — | US | disclosed |
| US-5939405-A | Phosphate derivatives of diaryl 1,3,4-oxadiazolone | BRISTOL-MYERS SQUIBB COMPANY (US) | 1999-08-17 | — | — | US | disclosed |
| WO-1999038510-A1 | DERIVATIVES OF 1,3,4-OXADIAZOLONE | BRISTOL-MYERS SQUIBB COMPANY (US) | 1999-08-05 | — | — | WO | disclosed |
| WO-1999038873-A1 | PHOSPHATE DERIVATIVES OF DIARYL 1,3,4-OXADIAZOLONE | BRISTOL-MYERS SQUIBB COMPANY (US) | 1999-08-05 | — | — | WO | disclosed |
| WO-1999038854-A1 | BENZOATE DERIVATIVES OF DIARYL 1,3,4-OXADIAZOLONE | BRISTOL-MYERS SQUIBB COMPANY (US) | 1999-08-05 | — | — | WO | disclosed |
| US-5869509-A | TREAT DISORDERS RESPONSIVE TO OPENERS OF THE LARGE CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS | BRISTOL-MYERS SQUIBB COMPANY (US) | 1999-02-09 | — | — | US | disclosed |